The Ongoing Debate: Concerns About Pediatric GLP-1 Use Critics raise several significant concerns: Growth and Development: Impact during crucial developmental years Hormonal Effects: Potential interference with puberty and bone building Psychological Impact: Risk of trauma from the medicalization of body image Long-term Effects: Limited data on lifetime use starting in childhood Eating Disorders: Concerns from organizations like the Collaborative of Eating Disorders Organizations Some physicians have cried foul, arguing that the introduction of these medications during a period of significant growth and development could come with adverse health effects
How Their Mechanisms Differ GHK-Cu stimulates collagen and elastin production, upregulates VEGF, and offers anti-DHT and antioxidant protection
Taurine improves congestive functions in a mouse model of fragile X syndrome
DPP-4 is known to inactivate GLP-1 when compared with healthy control study participants (14), which is believed to have led to higher levels of central fat distribution
Ultrasound can measure dermal thickness and collagen density without a biopsy, making it one of the more reliable "before and after" tools in dermatology
Research into the efficacy of GLP-1 drugs found that, in a clinical trial setting, Semaglutide (Ozempic and Wegovy) could result in a 14.9% reduction in body weight over the course of 68 weeks
